Patient’s Data

Exhibits

Select the 3 dietary choices that are not part of the recommended diet gout.

B. Combining opioid and non-opioid medications can provide more effective pain relief through synergistic effects and may allow for lower opioid dosages, reducing the risk of opioid-related side effects and improving pain control. Non-opioid medications such as acetaminophen or nonsteroidal anti-inflammatory drugs (NSAIDs) can complement the analgesic effects of opioids and provide additional pain relief.
A. While educating the client on signs and symptoms of narcotic dependency is important for long-term opioid use, it is not the most immediate intervention for managing severe pain in a client with stage IV bone cancer.
C. Pain management should aim to prevent pain from reaching severe levels, as it can be more difficult to control once it becomes severe.
D. Alternating between IV and IM analgesic medications may be considered in some situations to provide continuous pain relief while minimizing side effects. However, it is not typically the first-line approach for managing severe pain in a hospitalized client with stage IV bone cancer.

B. SIADH is characterized by excessive release of antidiuretic hormone (ADH), leading to water retention and dilutional hyponatremia. Fluid restriction is a key component of treatment for SIADH to restore serum sodium levels to normal. Maintaining the prescribed fluid restriction is important for preventing further dilution of serum sodium and promoting continued improvement in the client's condition.
A. Withholding the next scheduled dose of treatment may not be appropriate solely based on a mild increase in serum sodium level. While syndrome of inappropriate antidiuretic hormone (SIADH) can lead to hyponatremia (low sodium levels) due to excessive water retention, an increase in serum sodium within a narrow range may not necessarily warrant withholding treatment.
C. Assessing for increasing fluid volume overload may be relevant in the context of managing SIADH and monitoring the client's response to treatment. However, an increase in serum sodium level from 120 mEq/L to 125 mEq/L suggests a trend towards correction of hyponatremia rather than worsening fluid volume overload.
D. Increasing the frequency of neurologic checks to every 2 hours may not be necessary solely based on a mild increase in serum sodium level from 120 mEq/L to 125 mEq/L.